EUVIMEDEUVIMED entdecken
Crossref

Metformin inhibits NF-κB p65/RelA–NLRP3 inflammasome–IL-1β axis, attenuates lipid droplet accumulation, and reprograms CD14/CD16 expression in monocytes exposed to colorectal tumor-conditioned medium

Nihel Chahinez Djebri, Souad Zoudji, Aida Messaoud, Rabia Messali, Salim Loudjedi, Mourad Aribi

International Immunopharmacology · 2025

DOI: 10.1016/j.intimp.2025.115299 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Nihel Chahinez Djebri und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Applied Molecular Biology and Immunology, W0414100, University of Tlemcen, 13000 Tlemcen, Algeria. Hauptthemen laut MEDLINE: Metformin, Monocytes, Colorectal Neoplasms, Lipid Droplets. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 166 Literaturangaben. Gefördert von: Directorate General for Scientific Research and Technological Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Colorectal cancer (CRC) generates a complex tumor microenvironment (TME) known to profoundly alter the function and phenotype of immune cells, including monocytes. Key aspects of this environment can be mimicked by tumor-conditioned medium (TCM). Metformin has emerged as a promising candidate to counteract TCM-induced immune and inflammatory dysregulation. Therefore, this study aimed to evaluate the effects of metformin on NOD-like receptor family pyrin domain containing 3 (NLRP3) inflammasome expression, monocyte subset distribution, and lipid droplet (LD) accumulation upon exposure to colorectal TCM. METHODS: Assays were performed on primary human monocytes exposed to colorectal TCM in the presence or absence of metformin. RESULTS: TCM significantly increased nitric oxide (NO, p 0.05). CONCLUSIONS: Our findings highlight metformin's selective immunometabolic reprogramming capacity in monocytes exposed to colorectal tumor-derived signals, supporting its potential as a context-specific immunomodulator. This study lays the groundwork for future translational research on metformin as an adjunctive agent in inflammation-driven tumor settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetforminMonocytesColorectal NeoplasmsLipid DropletsHumansNLR Family, Pyrin Domain-Containing 3 ProteinInterleukin-1betaInflammasomesCulture Media, ConditionedTranscription Factor RelALipopolysaccharide ReceptorsReceptors, IgGSignal TransductionTumor MicroenvironmentCells, Cultured

Stichwörter der Autor:innen

Colorectal cancerLipid dropletsMetforminMonocyte subsetsNF-κB p65/RelANLRP3 inflammasomeTumor microenvironmentTumor-conditioned medium

Substanzen

MetforminNLR Family, Pyrin Domain-Containing 3 ProteinInterleukin-1betaInflammasomesNLRP3 protein, humanCulture Media, ConditionedTranscription Factor RelALipopolysaccharide ReceptorsReceptors, IgGIL1B protein, human

Autor:innen und Institutionen

  • Laboratory of Applied Molecular Biology and Immunology, W0414100, University of Tlemcen, 13000 Tlemcen, Algeria.
  • Laboratory of Applied Molecular Biology and Immunology, W0414100, University of Tlemcen, 13000 Tlemcen, Algeria; Surgery Department B of Tlemcen University Hospital Center, 13000 Tlemcen, Algeria.
  • Laboratory of Applied Molecular Biology and Immunology, W0414100, University of Tlemcen, 13000 Tlemcen, Algeria. Electronic address: mourad.aribi@univ-tlemcen.dz.

Förderung

  • Directorate General for Scientific Research and Technological Development

Zitieren

APA

Djebri, N. C., Zoudji, S., Messaoud, A., Messali, R., Loudjedi, S., & Aribi, M. (2025). Metformin inhibits NF-κB p65/RelA–NLRP3 inflammasome–IL-1β axis, attenuates lipid droplet accumulation, and reprograms CD14/CD16 expression in monocytes exposed to colorectal tumor-conditioned medium. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.115299

Vancouver

Djebri NC, Zoudji S, Messaoud A, Messali R, Loudjedi S, Aribi M. Metformin inhibits NF-κB p65/RelA–NLRP3 inflammasome–IL-1β axis, attenuates lipid droplet accumulation, and reprograms CD14/CD16 expression in monocytes exposed to colorectal tumor-conditioned medium. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2025.115299

BibTeX
@article{Djebri2025,
  author = {Djebri, Nihel Chahinez and Zoudji, Souad and Messaoud, Aida and Messali, Rabia and Loudjedi, Salim and Aribi, Mourad},
  title = {Metformin inhibits NF-κB p65/RelA–NLRP3 inflammasome–IL-1β axis, attenuates lipid droplet accumulation, and reprograms CD14/CD16 expression in monocytes exposed to colorectal tumor-conditioned medium},
  journal = {International Immunopharmacology},
  year = {2025},
  doi = {10.1016/j.intimp.2025.115299}
}
Kostenlos starten →